Company intelligence / Profile preview
FHL Therapeutics
Seoul, South Korea
- Ownership
- Private
- Development stage
- Other
01
Overview
FHL Therapeutics is a clinical-stage biotechnology company specializing in the development of innovative RNA interference (RNAi) therapies for difficult-to-treat cancers. The company's lead candidate, FHL-101, is a small interfering RNA (siRNA) therapeutic designed to target Hypoxia-inducible factor 1-alpha (HIF-1α), a key driver of tumor growth and resistance in glioblastoma multiforme. By utilizing a proprietary delivery system, FHL Therapeutics aims to overcome the challenges of blood-brain barrier penetration and systemic stability. The company is currently advancing its pipeline through clinical trials in both the United States and South Korea, focusing on neuro-oncology and other solid tumors.
- Therapeutic areas
- Oncology
- Modalities
- Small interfering RNARNA therapy
- Industry
- Biotech
02
Drug pipeline
3 assets2 more assets in the full pipeline.
Request access →03
Partnerships
Dana-Farber Cancer Institute
Beyond the preview
Go deeper on FHL Therapeutics.
Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.
Clinical trials
Full profile accessFollow clinical development from trial design and recruitment through results.
- Trial phase
- Status
- Readouts
Licensing & deals
Full profile accessExplore licensing agreements, acquisitions, and the assets behind each deal.
- Partners
- Deal terms
- Milestones
Funding history
Full profile accessTrace financing activity and the investors behind a company’s development.
- Funding rounds
- Investors
- Capital raised
Competitive landscape
Full profile accessCompare peer pipelines by target, modality, and therapeutic area.
- Peer companies
- Targets
- Pipeline overlap
Technologies & patents
Full profile accessExplore technology platforms and the patent landscape around relevant assets.
- Platforms
- Patents
- Assignees
Research & analysis
Full profile accessConnect company news and source material to the questions you’re investigating.
- Company news
- Sources
- Analysis
Bring the full picture into focus.
See how Gosset can support your research on FHL Therapeutics.